Repurposing the Serotonin Agonist Tegaserod as an Anticancer Agent in Melanoma: Molecular Mechanisms and Clinical Implications
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-020-1539-7
Full Text
Open PDFAbstract
Available in full text
Date
February 21, 2020
Authors
Publisher
Springer Science and Business Media LLC